1-2 of 2
Caramazza Domenica, MD
Close
Sort by
Journal Articles

A New International Multicenter-Based Model to Predict Survival in Myelofibrosis Secondary to Polycythemia and Thrombocythemia: The Mysec Prognostic Model (MYSEC-PM)

Francesco Passamonti, MD, Vannucchi Alessandro, MD, Caramazza Domenica, MD, Rambaldi Alessandro, MD, Morra Enrica, MD, Kiladjian Jean Jacques, Rami S Komrokji, MD, Margherita Maffioli, MD, Jason Gotlib, MD, Cervantes Francisco, MD PhD, Timothy Devos, MD PhD, Richard T. Silver, MD, Paola Guglielmelli, MD, Nicola Vianelli, MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Giorgina Specchia, MD, Umberto Vitolo, MD, Elisa Rumi, MD, Barbara Mora, MD, Tiziano Barbui, MD, Lisa Pieri, MDPhD, Cristiana Pascutto, PhD, Mario Cazzola, MD
Journal: Blood
Blood (2014) 124 (21): 1826.
https://doi.org/10.1182/blood.V124.21.1826.1826
Published: 2014
Journal Articles

Impact Of Ruxolitinib On The Natural History Of Patients With Primary Myelofibrosis: A Retrospective Comparison Of The DIPSS and The Comfort-2 Cohorts

Francesco Passamonti, MD, Margherita Maffioli, MD, Francisco Cervantes, MD, PhD, Alessandro M. Vannucchi, MD, PhD, Enrica Morra, MD, Tiziano Barbui, MD, Caramazza Domenica, MD, Elisa Rumi, MD, Gisslinger Heinz, Laurent Knoops, MD, PhD, Barbara Mora, MD, Norbert Hollaender, PhD, Margaret Squier, MD, PhD, Cristiana Pascutto, Claire N Harrison, DM, FRCP, FRCPath, Mario Cazzola, MD
Journal: Blood
Blood (2013) 122 (21): 4066.
https://doi.org/10.1182/blood.V122.21.4066.4066
Published: 2013